Epidemiology, Risk Assessment, and Biomarkers for Patients with Advanced Renal Cell Carcinoma
In the preceding two decades, several milestones have been reached in the management of patients with metastatic renal cell carcinoma (mRCC), including the development of novel targeted agents paralleling an…